Cargando…
Analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates
The European pharmacopeia provides analytical methods for the chemical characterization of active pharmaceutical ingredients (APIs). However, the complexity of some APIs exceeds the limitations of the currently prevailing physicochemical methods. Sodium bituminosulfonate (SBS) is described by the co...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149445/ https://www.ncbi.nlm.nih.gov/pubmed/36401638 http://dx.doi.org/10.1007/s00216-022-04393-w |
_version_ | 1785035164200468480 |
---|---|
author | Schwalb, Lukas Tiemann, Ole Käfer, Uwe Gröger, Thomas Rüger, Christopher Paul Gayko, Guido Zimmermann, Ralf |
author_facet | Schwalb, Lukas Tiemann, Ole Käfer, Uwe Gröger, Thomas Rüger, Christopher Paul Gayko, Guido Zimmermann, Ralf |
author_sort | Schwalb, Lukas |
collection | PubMed |
description | The European pharmacopeia provides analytical methods for the chemical characterization of active pharmaceutical ingredients (APIs). However, the complexity of some APIs exceeds the limitations of the currently prevailing physicochemical methods. Sodium bituminosulfonate (SBS) is described by the collection of key parameters of generalizing criteria such as dry matter, sulfur and sodium content, and neutrality, but techniques to unravel the complexity on a molecular level are lacking. We present a study based on online derivatization with tetramethylammonium hydroxide in combination with comprehensive two-dimensional gas chromatography coupled to an electron ionization high-resolution time-of-flight mass spectrometer (GC × GC-HR-ToF–MS) for the chemical description of SBS as well as its process intermediates. The application of GC × GC allowed the comprehensive description of the chemical components in the API and the process intermediates for the first time. Furthermore, it was possible to classify peaks regarding their elemental and structural composition based on accurate mass information, elution behavior, and mass fragmentation pattern. This work demonstrates not only the general applicability, advantages but also limitations of GC × GC for the characterization of APIs for complex drugs. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-022-04393-w. |
format | Online Article Text |
id | pubmed-10149445 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-101494452023-05-02 Analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates Schwalb, Lukas Tiemann, Ole Käfer, Uwe Gröger, Thomas Rüger, Christopher Paul Gayko, Guido Zimmermann, Ralf Anal Bioanal Chem Research Paper The European pharmacopeia provides analytical methods for the chemical characterization of active pharmaceutical ingredients (APIs). However, the complexity of some APIs exceeds the limitations of the currently prevailing physicochemical methods. Sodium bituminosulfonate (SBS) is described by the collection of key parameters of generalizing criteria such as dry matter, sulfur and sodium content, and neutrality, but techniques to unravel the complexity on a molecular level are lacking. We present a study based on online derivatization with tetramethylammonium hydroxide in combination with comprehensive two-dimensional gas chromatography coupled to an electron ionization high-resolution time-of-flight mass spectrometer (GC × GC-HR-ToF–MS) for the chemical description of SBS as well as its process intermediates. The application of GC × GC allowed the comprehensive description of the chemical components in the API and the process intermediates for the first time. Furthermore, it was possible to classify peaks regarding their elemental and structural composition based on accurate mass information, elution behavior, and mass fragmentation pattern. This work demonstrates not only the general applicability, advantages but also limitations of GC × GC for the characterization of APIs for complex drugs. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-022-04393-w. Springer Berlin Heidelberg 2022-11-19 2023 /pmc/articles/PMC10149445/ /pubmed/36401638 http://dx.doi.org/10.1007/s00216-022-04393-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Paper Schwalb, Lukas Tiemann, Ole Käfer, Uwe Gröger, Thomas Rüger, Christopher Paul Gayko, Guido Zimmermann, Ralf Analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates |
title | Analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates |
title_full | Analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates |
title_fullStr | Analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates |
title_full_unstemmed | Analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates |
title_short | Analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates |
title_sort | analysis of complex drugs by comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry: detailed chemical description of the active pharmaceutical ingredient sodium bituminosulfonate and its process intermediates |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149445/ https://www.ncbi.nlm.nih.gov/pubmed/36401638 http://dx.doi.org/10.1007/s00216-022-04393-w |
work_keys_str_mv | AT schwalblukas analysisofcomplexdrugsbycomprehensivetwodimensionalgaschromatographyandhighresolutionmassspectrometrydetailedchemicaldescriptionoftheactivepharmaceuticalingredientsodiumbituminosulfonateanditsprocessintermediates AT tiemannole analysisofcomplexdrugsbycomprehensivetwodimensionalgaschromatographyandhighresolutionmassspectrometrydetailedchemicaldescriptionoftheactivepharmaceuticalingredientsodiumbituminosulfonateanditsprocessintermediates AT kaferuwe analysisofcomplexdrugsbycomprehensivetwodimensionalgaschromatographyandhighresolutionmassspectrometrydetailedchemicaldescriptionoftheactivepharmaceuticalingredientsodiumbituminosulfonateanditsprocessintermediates AT grogerthomas analysisofcomplexdrugsbycomprehensivetwodimensionalgaschromatographyandhighresolutionmassspectrometrydetailedchemicaldescriptionoftheactivepharmaceuticalingredientsodiumbituminosulfonateanditsprocessintermediates AT rugerchristopherpaul analysisofcomplexdrugsbycomprehensivetwodimensionalgaschromatographyandhighresolutionmassspectrometrydetailedchemicaldescriptionoftheactivepharmaceuticalingredientsodiumbituminosulfonateanditsprocessintermediates AT gaykoguido analysisofcomplexdrugsbycomprehensivetwodimensionalgaschromatographyandhighresolutionmassspectrometrydetailedchemicaldescriptionoftheactivepharmaceuticalingredientsodiumbituminosulfonateanditsprocessintermediates AT zimmermannralf analysisofcomplexdrugsbycomprehensivetwodimensionalgaschromatographyandhighresolutionmassspectrometrydetailedchemicaldescriptionoftheactivepharmaceuticalingredientsodiumbituminosulfonateanditsprocessintermediates |